Human Reproduction, Vol. 6, No. 7, pp. 953-958, 1991
© 1991 European Society of Human Reproduction and Embryology
other |
The ESHRE multicentre trial on the treatment of unexplained infertility: a preliminary report*
II Department of Obstetrics and Gynaecology, University of Milan Milan, Italy 2Cambridge Research Station, Babraham Hall Cambridge CB2 4AT, UK
Correspondence: 1To whom correspondence should be addressed
Nineteen** European fertility centres participated in a controlled randomized trial aimed at comparing the effectiveness of five methods for the treatment of unexplained infertility. Each centre was invited to employ two of the five treatments being investigated, and the treatment allocated to individual patients was then decided by randomization. The treatments were superovulation alone, and superovulation together with one of the following procedures: intra-uterine insemination (IUI), intra-peritoneal insemination (IPI), gamete intra-Fallopian transfer (GIFT), in-vitro fertilization (IVF). All the patients admitted to the study had experienced >36 months infertility prior to the start of the trial, and only patients <38 years of age were included in the investigation. Further, the study was confined to patients with normal Fallopian tubes, and where there was evidence of spontaneous ovulation. Yet another prerequisite for inclusion in the study was that the male partner was normal as regards fertility. Due to unavoidable practical difficulties, the experimental design eventually obtained was severely unbalanced. Nevertheless, objective statistical comparisons were possible among the five treatments, using non-orthogonal analyses of variance. By the completion of the trial 444 patients had been treated in a total of 649 cycles. There was some statistical evidence that the pregnancy rate obtained from superovulation alone was inferior to that obtained by using superovulation together with one of the methods of assisted conception. The pregnancy rate from each method of assisted procreation was found to be vastly better than various estimates of the spontaneous pregnancy rates cited in the literature, and also of the upper limit of the pregnancy rate implied by the pre-treatment period of infertility.
Key words: randomized trials/multicentre/assisted procreation/pregnancy rates
*European Society of Human Reproduction and Embryology. This trial received financial support from ARES-SERONO (Geneva)
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H.K. Snick, J.A. Collins, and J.L.H. Evers What is the most valid comparison treatment in trials of intrauterine insemination, timed or uninfluenced intercourse? A systematic review and meta-analysis of indirect evidence Hum. Reprod., October 1, 2008; 23(10): 2239 - 2245. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.M.E. van Rumste, J.E. den Hartog, J.C.M. Dumoulin, J.L.H. Evers, and J.A. Land Is controlled ovarian stimulation in intrauterine insemination an acceptable therapy in couples with unexplained non-conception in the perspective of multiple pregnancies? Hum. Reprod., March 1, 2006; 21(3): 701 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Stewart Stimulated intra-uterine insemination is not a natural choice for the treatment of unexplained subfertility: Should the guidelines be changed? Hum. Reprod., May 1, 2003; 18(5): 903 - 907. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lahat, A. Raziel, S. Friedler, M. Schieber-Kazir, and R. Ron-El Long-term follow-up of children born after inadvertent administration of a gonadotrophin-releasing hormone agonist in early pregnancy Hum. Reprod., October 1, 1999; 14(10): 2656 - 2660. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nuojua-Huttunen, C. Tomas, R. Bloigu, L. Tuomivaara, and H. Martikainen Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome Hum. Reprod., March 1, 1999; 14(3): 698 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Forti and C. Krausz Evaluation and Treatment of the Infertile Couple J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4177 - 4188. [Full Text] |
||||

